World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
9553
World Ranking
4502
National Ranking
2036

Roshini S. Abraham publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Roshini S. Abraham sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 195 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Roshini S. Abraham D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Roshini S. Abraham sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Roshini S. Abraham is affiliated with Nationwide Children's Hospital in the United States and has contributed extensively to research in the fields of medicine and immunology. Their work spans multiple subfields, including immunology, genetics, epidemiology, molecular biology, and infectious diseases.

The research topics frequently addressed by Abraham include immunodeficiency and autoimmune disorders, blood disorders and treatments, immune cell function and interaction, T-cell and B-cell immunology, cystic fibrosis research advances, cytomegalovirus and herpesvirus research, and chronic lymphocytic leukemia research.

Abraham has published research in several notable scientific venues, with frequent contributions to Clinical Immunology, Journal of Allergy and Clinical Immunology, Journal of Clinical Immunology, Pathology, and Frontiers in Immunology.

Among recent papers authored or coauthored by Abraham are:

  • Coronavirus disease 2019 in patients with inborn errors of immunity: An international study (2020, Journal of Allergy and Clinical Immunology)
  • The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions (2022, Journal of Allergy and Clinical Immunology)
  • PAX1 is essential for development and function of the human thymus (2020, Science Immunology)
  • Evaluation and Management of Deficiency of Adenosine Deaminase 2 (2023, JAMA Network Open)
  • A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors (2020, Frontiers in Immunology)

Abraham collaborates extensively with other researchers in the field, frequently publishing alongside colleagues such as Luigi D. Notarangelo, Amrita Basu, Jennifer Heimall, Jennifer M. Puck, and Avni Y. Joshi.

Best Publications

  • Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

    Jerry A. Katzmann;Raynell J. Clark;Roshini S. Abraham;Sandra Bryant

  • Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

    Antonia Kwan;Roshini S. Abraham;Robert Currier;Amy Brower

  • Common variable immunodeficiency: a new look at an old disease

    Miguel A. Park;James T. Li;John Bryant Hagan;Daniel E. Maddox

  • Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

    Y N Naumov;K S Bahjat;R Gausling;R Abraham

  • Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study.

    Isabelle Meyts;Giorgia Bucciol;Isabella Quinti;Bénédicte Neven

  • Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Martha Q. Lacy;Jerry A. Katzmann;S. Vincent Rajkumar

  • Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain–associated amyloidosis (AL)

    Roshini S. Abraham;Susan M. Geyer;Tammy L. Price-Troska;Cristine Allmer

  • Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.

    Jerry A. Katzmann;Angela Dispenzieri;Robert A. Kyle;Melissa R. Snyder

  • Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

    Roshini S. Abraham;Jerry A. Katzmann;Raynell J. Clark;A.R. Bradwell

  • Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency

    Jolan E. Walter;Lindsey B. Rosen;Krisztian Csomos;Jacob M. Rosenberg

  • Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.

    Roshini S. Abraham;Raynell J. Clark;Sandra C. Bryant;James F. Lymp

  • Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages.

    Roshini Abraham;Nagendra Singh;Amitabha Mukhopadhyay;S. K. Basu

  • Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience

    Konstantinos N Lazaridis;Kimberly A. Schahl;Margot A. Cousin;Dusica Babovic-Vuksanovic

  • Short telomere syndromes cause a primary T cell immunodeficiency

    Christa L. Wagner;Vidya Sagar Hanumanthu;C. Conover Talbot;Roshini S. Abraham

  • Trimolecular Complexes of λ Light Chain Dimers in Serum of a Patient with Multiple Myeloma

    Roshini S. Abraham;M. Cristine Charlesworth;Barbara A.L. Owen;Linda M. Benson

  • Dermatologic Features of ADA2 Deficiency in Cutaneous Polyarteritis Nodosa

    Tania M. Gonzalez Santiago;Andrey Zavialov;Janna Saarela;Mikko Seppanen

  • Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution.

    Keith A Sacco;Roshini S Abraham

  • Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency

    Kit L. Shaw;Elizabeth Garabedian;Suparna Mishra;Provaboti Barman

  • PAX1 is essential for development and function of the human thymus

    Yasuhiro Yamazaki;Raul Urrutia;Luis M. Franco;Silvia Giliani

  • A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).

    Irbaz Bin Riaz;Warda Faridi;Mrinal M. Patnaik;Roshini S. Abraham

  • Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

    Roshini S. Abraham;Geraldine Aubert

  • Modulation of T Cell Cytokine Profiles and Peptide-MHC Complex Availability In Vivo by Delivery to Scavenger Receptors via Antigen Maleylation

    Nagendra Singh;Sumeena Bhatia;Roshini Abraham;Sandip K. Basu

  • Common variable immunodefi ciency: a new look at an old disease

    Miguel A Park;James T Li;John B Hagan;Daniel E Maddox

Frequent Co-Authors

Jolan E. Walter
Jolan E. Walter University of South Florida
Robert A. Kyle
Robert A. Kyle Mayo Clinic
Morie A. Gertz
Morie A. Gertz Mayo Clinic
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
Jordan S. Orange
Jordan S. Orange University of Pennsylvania
Chella S. David
Chella S. David Mayo Clinic
James T. Li
James T. Li Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare-related fields, especially within nursing and advanced practice roles. For those interested in transitioning into nursing without a prior background, online ABSN programs for non nurses offer accelerated pathways that combine flexibility with comprehensive training.

If gaining admission to a program quickly is a priority, many students explore the easiest accelerated nursing programs to get into, which provide streamlined entry while maintaining quality education. These programs help prepare students for foundational nursing roles efficiently.

For those looking to begin their nursing careers at a practical level, the fastest and easiest LPN programs can be an excellent entry point, focusing on essential skills and patient care with relatively swift completion times.

Advancing beyond initial nursing qualifications, many Immunology graduates consider becoming a Nurse Practitioner. Exploring the easiest nurse practitioner degree programs can help identify suitable options that balance accelerated progression with academic rigor.

Best Scientists Citing Roshini S. Abraham

Trending Scientists